Voltage-gated ion channels of cutaneous sensory nerve endings (VGICs)

Voltage-gated ion channels (VGICs) located on cutaneous sensory nerve endings are specialized transmembrane proteins that play a fundamental role in the peripheral nervous system by mediating the sensation of touch, pain, and temperature. These channels, which include various subtypes of voltage-gated sodium (Nav), calcium (Cav), and potassium (Kv) channels, respond to changes in membrane potential to generate and conduct electrical signals from the skin to the spinal cord (PubMed: 27023313). In pathological conditions such as peripheral neuropathy, inflammation, or nerve injury, the expression and gating properties of these channels are often altered, leading to neuronal hyperexcitability and chronic pain states (StatPearls: NBK537247). For instance, the Nav1.7, Nav1.8, and Nav1.9 sodium channel subtypes are highly expressed in nociceptors and are key targets for analgesic development (NIH: PMC4913303). Pharmacological modulation of these channels, either through broad-spectrum local anesthetics or subtype-selective inhibitors like Suzetrigine, aims to interrupt the transmission of pain signals while minimizing effects on other physiological processes. Understanding the distribution and function of these channels is crucial for developing targeted therapies for conditions like erythromelalgia, small fiber neuropathy, and various forms of pruritus (PubMed: 24321350).

Other names

Peripheral sensory nerve ion channelsCutaneous nociceptor ion channelsVoltage-gated sodium channels (Nav)Voltage-gated calcium channels (Cav)Voltage-gated potassium channels (Kv)Sodium channel protein type 9 subunit alpha (Nav1.7)Sodium channel protein type 10 subunit alpha (Nav1.8)Voltage-dependent N-type calcium channel subunit alpha-1B (Cav2.2)

Drugs targeting these channels typically act as pore blockers or allosteric modulators that inhibit the influx of ions (primarily sodium or calcium), thereby increasing the threshold for action potential firing or preventing the propagation of pain signals to the central nervous system (PubMed: 27023313).